Vol. 5, Issue 2, Part A (2023)

Background: Adenoid hypertrophy is a common issue observed in childhood, with an estimated prevalence of 34.46% in children. This study aimed to objectively assess the impact of the topical nasal steroid Mometasone furoate on adenoidal hypertrophy in children. 
Methods: This observational prospective study was done on 106 patients aged from 4 to 8 years old, both sexes, presented with nasal obstructive symptoms and diagnosed with adenoid hypertrophy based on lateral x-ray nasopharynx with A/N ratio >0.73 using Fujioka method.
Results: A/N ratio before intervention with Mean ± SD = 0.78±0.45, while after intervention with Mean ± SD= 0.70±0.47, with high significance between 2 measurements. There was no impact of sex and age on intervention efficacy in A/N ratio reduction after and before intervention. SNOT22 score before intervention was reduced after intervention with high significance (p<0.001). There was high statistical significance (p<0.001) between 2 measurements regarding change of nasal obstruction in SNOT22 score values.
Conclusions: Topical nasal steroid intervention led to a significant reduction in adenoid size and symptoms associated with adenoid hypertrophy and improvement in the quality of life. Age and sex did not significantly impact the intervention's effectiveness. Additionally, no adverse events were reported, indicating the safety of the intervention.